Blog by Anouck Kluytmans, researcher in early health technology assessment methodology at the Department for Health Evidence.Accompanied by four lively examples, our Radboudumc proudly presents her vision on healthcare of the future. Personalized and innovative; that is how we’ll become a leading force in sustainable, innovative, and affordable healthcare. In our enthusiasm we seem to be overlooking that these noble causes are often at odds with one another.
An academic medical network with regard for the individual patient and innovation that leads us into the future – who could disagree? After all, who would like to be treated a dime a dozen using last century’s technology? The vision of the Radboudumc strongly appeals to our intuition. New is better. Or is it?
Perhaps it’s in our nature? We’re so good at attracting innovation – and so poorly equipped to resist. Indeed, patients may punish our institution when we neglect to hop the next big robotics train, or when we bravely disinvest in technology that turned out to be more than we bargained for. Once innovation enters our doors, vested interests and psychological biases will keep it there.
In my field of health technology assessment there is emerging awareness that the promise of innovation is limited. To be more precise, the value of innovation is limited by what we’re already achieving in healthcare today and by the constraints in our resources.
Mine is not a plea to ignore the future and change nothing. Rather, there’s hard work ahead of us in finding out what and how we want to change first. We find ourselves amidst a wave of innovation, each one more promising than its predecessor. Time and again we see the perfect novel solution to a problem that does not really exist. Impressive, high-level technology whose added value to the real-world patient is unclear at best. At an incremental price to our already overburdened budget, of course, stressing the accessibility of our healthcare system in the future. What I think we need and what I missed so much, is to take that one step back that allows us to reflect.
Before asking for solutions we should focus on identifying problems and needs. Where are the biggest windows of opportunity? What kind of innovation do we need? Being brave enough to make choices is one of Radboudumc’s strengths I’ve been missing in this recent strategy acceleration.
Innovation, sustainability, and affordability is a challenging triangle to navigate. Keeping the balance requires a priori critical evaluation of which innovations to pursue and why. We need complex, scary, real-world decision-making before swinging our doors wide open.
Anouck Kluytmans, MSc
member of the theme Healthcare improvement science
Related news items
Study expected to improve prediction of the results of cochlear implants29 January 2020
Emmanuel Mylanus and Wendy Huinck of the ENT department of Radboud university medical center have received a Horizon 2020 grant of €1 million for the MOSAICS project.read more
Cognitive behavioral therapy reduces severe fatigue in patients with advanced cancer during treatment28 January 2020
In Annals of Oncology, RIHS researchers Hanneke Poort, Marlies Peters, Winette van der Graaf, Ria Nijhuis-van der Sanden and colleagues showed significant effects of cognitive behavioral therapy on fatigue in patients with advanced cancer during treatment with palliative intent.read more
Prinses Beatrix Spierfonds grant to investigate patient stratification in myotonic dystrophy24 January 2020
Rick Wansink and Roland Brock, both theme Nanomedicine, received a € 280,000 grant from the Prinses Beatrix Spierfonds.read more
RIMLS PhD retreat registration is open23 January 2020
Yearly, RIMLS PhD candidates gather for the two-day PhD Retreat. Apart from the science, this event is highly valued for the opportunity to meet and get to know fellow PhD candidates during the social activities. Early bird registration and abstract submission deadline: 4 March 2020.read more
6 million euros to uncover link between metabolic and brain disorders21 January 2020
An important European-funded initiative, coordinated by Radboudumc researchers Barbara Franke, Jan Buitelaar, and Janita Bralten, has been launched to explore how common molecular mechanisms may link metabolic disorders with brain disorders.read more
NWO Open Competition Domain Science - XS grant for Ronald van Rij and Jenny van der Wijst21 January 2020
NWO Domain Science has awarded Ronald van Rij, theme Infectious diseases and global health and Jennny van der Wijst, theme Renal disorders an XS grant. The XS category emphatically strives to encourage curiosity-driven and bold research involving a relatively quick analysis of a promising idea.read more